Picankibart

DRUG3 trials

Sponsors

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD., Xijing Hospital

Conditions

Palmoplantar PustulosisPlaque PsoriasisPsoriatic Arthritis

Phase 2

A Study of Picankibart in Patients With Active Psoriatic Arthritis

RecruitingNCT07295509

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Psoriatic Arthritis

Start: 2025-12-18End: 2029-12-31Target: 222Updated: 2026-03-20

Phase 3

A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy

Active, not recruitingNCT06945107

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Plaque Psoriasis

Start: 2025-05-27End: 2027-01-19Updated: 2026-03-25

Unknown Phase

Picankibart in Palmoplantar Pustulosis

RecruitingNCT07552454

Xijing HospitalPalmoplantar Pustulosis

Start: 2026-04-15End: 2027-12-31Target: 60Updated: 2026-04-27